Macquarie Atlas Roads - Morgans

1 downloads 184 Views 503KB Size Report
Apr 9, 2018 - Mackay. +61 7 4957 3033 Newcastle. +61 2 4926 4044 Canberra ... your local Morgans branch or write to GPO
Toll Roads│Australia│Equity research│April 9, 2018

Macquarie Atlas Roads MQA internalisation agreement

ADD (no change) Current price: Target price: Previous target: Up/downside: Reuters: Bloomberg: Market cap:

A$5.91 A$6.81 A$6.72 15.3% MQA.AX MQA AU US$3,044m A$3,958m US$18.01m A$23.08m 669.8m 84.0%

Average daily turnover: Current shares o/s Free float:

■ MQA has agreed with Macquarie the details of its internalisation. Costs are less than we expected (albeit run into FY19) with no obvious need for a capital raising.

■ FY18 DPS guidance is unchanged at 24 cps. After factoring in the agreement, our FY19F DPS declines while our forecast DPS from FY20F onwards increases.

■ Our 12 month target price increases 9 cps to $6.81 per share. ADD retained.

Agreement on management internalisation at the MQA level… Macquarie will remain MQA’s external manager until 15 May 2019. During this time, MQA will incur one-off internalisation-related costs (~$12m) as well as continue to pay base fees to Macquarie (say $33-34m pa at current market cap and fee structure). From the termination date, management fees to Macquarie cease but MQA will pay Macquarie $750k per month until end-CY19 for transition services. Performance fees payable to Macquarie cease after 30 June 2018. MQA estimates ongoing running costs on an internalised basis at $15-20m pa, compared to ~$4m currently.

…but still tied to Macquarie via the APRR/MAF2 structure

Vol m

Price Close

Relative to S&P/ASX 200 (RHS)

6.50

125.1

6.00

115.8

5.50

106.4

5.00 100 80 60 40 20

97.0

Apr-17

Jul-17

Oct-17

Jan-18

Modelling impact

Source: Bloomberg

Price performance Absolute (%) Relative (%)

No change has yet been made to the APRR/MAF2 management arrangements with Macquarie. Macquarie will start to receive fees for the ongoing management of MQA’s interest in the APRR from termination of the MQA management agreement. This includes a fixed base fee of €7.4m pa (~$11.9m pa). It also includes a performance fee equal to 15% of actual cashflows when MQA’s IRR exceeds 8% pa; the calculation starts on 16 May 2019 and is based on an agreed APRR valuation as at that date. The agreed valuation would need to be ~10% below our APRR valuation for MQA to accrue a performance fee by the end of the current concession term. MQA has promised to “actively work with Macquarie and other parties to see if mutually acceptable alternative arrangements can be achieved.”

1M 4.4 7

Nathan LEAD T (61) 7 3334 4548 E [email protected]

3M -5.1 0.2

12M 15 15.9

We had assumed internalisation would be completed in 1H18, with MQA paying Macquarie $111m for advisory and support costs funded by a capital raising. The agreement announced today means internalisation costs are only ~$18m spread across FY18-19 (thus no capital raising required), but MQA base fees are paid for 12 months more than we’d anticipated. Based on MQA’s agreement with Macquarie, we assume ~$78m of performance fees are paid in 2H18 via scrip issue as per historical precedent (vs $45m previously but depends on stock performance against the XKIAI). The MAF2 base fees and increase in fund running costs are in-line with our existing forecasts. The outcome is detrimental to FY19F MQA cashflows by 3.7 cps (costs run into FY19), but positive to FY20+ per share metrics by >1.0 cps (no capital raising required).

Investment view With clarity on MQA internalisation, fundamental factors (eg. APRR toll revenue growth, legislated French company tax rate cuts, substantial debt service savings due to expiry of the Eiffarie interest rate swaps in June 2018, declining AUDEUR) should drive the share price higher. However, we also watch cautiously for capital requirements related to the final exit of MEIF2 from the APRR (MQA will be involved in the pre-emptive sale process) and the potential MAF2 internalisation (the PV of future MAF2 base fees at a 7% pa discount rate is €116m).

Financial Summary

Dec-16A 18.0

Dec-17A 20.00

Dec-18E 24.0

Dec-19E 36.2

Dec-20E 43.1

Dec-21E 64.0

13% 3.0% 1,685

11% 3.4% 1,775

20% 4.1% 1,891

51% 6.1% 1,979

19% 7.3% 2,050

48% 10.8% 2,125

- growth D/Greenway EBITDA (100%, US$m)

6% 70

5% 74

7% 72

5% 74

4% 78

4% 82

- growth APRR distribution to MQA (A$m) DG distribution to MQA (A$m) MQA corporate costs (A$m) MQA cash balance (A$m)

6% 125 (35) 223

5% 147 (37) 40

-2% 225 (51) 46

2% 307 (49) 46

6% 323 (30) 46

4% 362 105 (30) 46

Distribution (A$ cps) - growth Distribution yield APRR EBITDA (100%, €m)

SOURCE: MORGANS, COMPANY REPORTS IMPORTANT DISCLOSURES REGARDING COMPANIES THAT ARE THE SUBJECT OF THIS REPORT AND AN EXPLANATION OF RECOMMENDATIONS CAN BE FOUND AT THE END OF THIS DOCUMENT. MORGANS FINANCIAL LIMITED (ABN 49 010 669 726) AFSL 235410 - A PARTICIPANT OF ASX GROUP

Powered by EFA

Toll Roads│Australia│Equity research│April 9, 2018

Figure 1: Financial summary Valuation summary APRR (25%) DG (100%) PV of Mgmt fees PV of Fund costs Fund cash MQA Equity value Shares on issue MQA Equity value

A$m A$m A$m A$m A$m A$m million $/share

Dec-18 4,265 547 (19) (186) 46 4,653 683 $6.81

Dec-19 4,269 597 (172) 46 4,740 683 $6.94

Dec-20 4,255 652 (168) 46 4,785 683 $7.01

Dec-21 4,199 603 (164) 46 4,685 683 $6.86

Dec-22 4,113 656 (158) 47 4,657 683 $6.82

Dec-23 3,994 711 (152) 47 4,600 683 $6.74

Dec-24 3,830 768 (144) 47 4,500 683 $6.59

Dec-25 3,650 825 (136) 47 4,386 683 $6.42

MQA cash summary APRR/Eiffarie distribution DG distribution Distributions received by MQA External mgmt fees paid Fund OpEx Other MQA cashflow

A$m A$m A$m A$m A$m A$m A$m

Dec-18 225 225 (35) (17) (5) 169

Dec-19 307 307 (20) (29) (11) 247

Dec-20 323 323 (30) 1 295

Dec-21 362 105 466 (30) 1 437

Dec-22 387 2 389 (31) 1 360

Dec-23 412 5 417 (31) 1 387

Dec-24 449 8 457 (31) 1 427

Dec-25 451 13 463 (32) 1 432

MQA distribution - total payment

cps A$m

5.7 (28)

13.2 (66)

16.0 (82)

18.0 (94)

20.0 (115)

24.0 (162)

36.2 (247)

43.1 (295)

64.0 (437)

52.7 (360)

56.7 (387)

62.4 (426)

63.3 (432)

Investments / sales Equity raising FX movements MQA cash balance

A$m A$m A$m A$m

1 18

(53) 59 0 30

12 1 65

154 7 223

(831) 647 7 40

46

46

0 46

0 46

47

0 47

0 47

47

APRR (100% basis) Traffic - growth Revenue - growth EBITDA - growth D&A Net interest Tax Other NPAT Operating CF Dividend paid Capex Net debt

bn kms % €m % €m % €m €m €m €m €m €m €m €m €bn

Dec-13A Dec-14A Dec-15A Dec-16A Dec-17A 21.3 21.7 22.2 23.1 23.8 0.8% 1.6% 2.7% 3.7% 3.2% 2,099 2,149 2,214 2,328 2,425 3.0% 2.4% 3.0% 5.1% 4.2% 1,475 1,520 1,589 1,685 1,775 3.4% 3.0% 4.5% 6.0% 5.3% (395) (404) (405) (397) (398) (331) (324) (278) (237) (182) (276) (332) (341) (351) (443) (32) (41) (27) (29) (46) 442 420 538 671 706 737 821 825 999 1,058 (400) (450) (425) (581) (672) (310) (316) (232) (337) (353) 6.8 6.7 7.4 7.1 7.0

Dec-18 24.5 3.0% 2,553 5.3% 1,891 6.6% (430) (142) (438) (46) 835 1,260 (731) (364) 6.9

Dec-19 25.0 2.1% 2,650 3.8% 1,979 4.7% (452) (115) (437) (47) 928 1,381 (811) (368) 6.7

Dec-20 25.4 1.6% 2,730 3.0% 2,050 3.6% (475) (108) (411) (47) 1,009 1,510 (889) (373) 6.4

Dec-21 25.8 1.6% 2,816 3.1% 2,125 3.7% (491) (107) (405) (48) 1,074 1,605 (959) (199) 6.0

Dec-22 26.2 1.6% 2,900 3.0% 2,199 3.5% (506) (99) (399) (49) 1,146 1,704 (1,028) (202) 5.5

Dec-23 26.6 1.6% 2,987 3.0% 2,274 3.4% (521) (86) (418) (49) 1,200 1,773 (1,093) (206) 5.1

Dec-24 27.1 1.6% 3,075 2.9% 2,349 3.3% (539) (72) (436) (50) 1,252 1,833 (1,187) (209) 4.6

Dec-25 27.5 1.6% 3,166 2.9% 2,427 3.3% (558) (57) (455) (51) 1,306 1,899 (1,281) (213) 4.2

Eiffarie (100% basis) Dividend received from APRR add: APRR tax transferred to FE less: Group tax paid add: Other less: Eiffarie net interest less: Eiffarie debt repayment Cash available for distribution Distribution paid by Eiffarie MQA ownership interest Distribution received by MQA Withholding tax on dividend Acquisition debt service Net distribution to MQA AUDEUR Net distribution to MQA Eiffarie Net debt

€m €m €m €m €m €m €m €m €m €m €m €m €m fx A$m €bn

Dec-13A Dec-14A Dec-15A Dec-16A Dec-17A 400 450 425 581 672 245 348 362 347 446 (71) (99) (121) (276) (376) (19) (2) 40 (146) (1) (224) (237) (180) (174) (174) (91) (112) (30) (70) (90) 241 342 492 257 473 184 330 423 417 503 19.4% 19.9% 20.1% 20.1% 20.1% 36 66 85 84 101 (1) 36 66 85 84 101 0.732 0.678 0.654 0.673 0.685 49 97 130 125 147 2.4 2.3 1.3 1.3 1.3

Dec-18 731 445 (390) (1) (94) (110) 581 587 25.0% 147 (3) 144 0.638 225 1.2

Dec-19 811 450 (442) (1) (20) 798 798 25.0% 200 (3) 196 0.639 307 1.2

Dec-20 889 425 (448) (1) (20) 844 844 25.0% 211 (4) 207 0.639 323 1.2

Dec-21 959 404 (399) (1) (20) 944 944 25.0% 236 (5) 231 0.639 362 1.2

Dec-22 1,028 398 (393) (1) (20) 1,012 1,012 25.0% 253 (6) 247 0.639 387 1.2

Dec-23 1,093 416 (411) (1) (20) 1,077 1,077 25.0% 269 (6) 263 0.639 412 1.2

Dec-24 1,187 436 (431) (1) (20) 1,172 1,172 25.0% 293 (6) 287 0.639 449 1.2

Dec-25 1,281 454 (449) (1) (28) 1,258 1,204 25.0% 301 (13) 288 0.639 451 1.2

Dulles Greenway (100% basis) EBITDA USA GAAP Debt service = P&I Pre-reserves cashflow Change in SDSRA and ERA Change in Improvement Fund Change in ERA Post-reserves cashflow Tax Acquisition facility debt service Distribution to MQA AUDUSD Distribution to MQA Net debt (incl. acquisition debt) ADSCR for 3 yr test (1.15x limit) ADSCR for 1 yr test (1.25x limit)

US$m US$m US$m US$m US$m US$m US$m US$m US$m US$m fx A$m US$m x x

Dec-13A Dec-14A Dec-15A Dec-16A Dec-17A 59 63 66 70 74 (57) (61) (62) (63) 4 8 13 (1) (1) 11 (3) 4 (1) (10) (23) (0) 0 0 864 858 1,023 1.03 1.18 1.18 1.10 1.18 1.18

Dec-18 72 (52) 21 (1) (12) 8 1,033 1.20 1.20

Dec-19 74 (53) 21 23 (36) 8 -

Dec-20 78 (30) 48 (8) 0 (40) -

1,043 1.25 1.25

1,045 1.31 1.34

Dec-21 82 (39) 43 (30) (0) 112 125 (44) 82 0.78 105 1,126 1.54 1.54

Dec-22 85 (69) 17 (1) (0) (2) 13 (11) 2 0.78 2 1,123 1.28 1.28

Dec-23 89 (70) 20 (1) (0) (3) 16 (11) 4 0.78 5 1,118 1.32 1.32

Dec-24 93 (71) 23 (1) (0) (3) 18 (12) 7 0.78 8 1,111 1.36 1.36

Dec-25 97 (72) 26 (1) (0) (3) 22 (12) 10 0.78 13 1,103 1.40 1.40

Dec-13A Dec-14A Dec-15A Dec-16A Dec-17A 49 97 130 125 147 49 97 130 125 147 (18) (23) (25) (30) (31) (4) (3) (4) (4) (7) 4 2 3 1 (0) 31 72 105 91 109

SOURCE: MORGANS RESEARCH, COMPANY

2

Toll Roads│Australia│Equity research│April 9, 2018

Figure 2: Changes to forecasts 2017 actual

old

2018F new

r%

old

2019F new

r%

old

2020F new

r%

old

2021F new

r%

APRR (100% basis, 20.1% MQA owned): Traffic Mn VKT Revenue €m EBITDA €m Group debt service €m Group tax paid €m Dist'n to MQA A$m Net debt exc acquisition debt €bn

23.8 2,425 1,775 (410) (376) 147 8.3

24.5 2,553 1,891 (279) (390) 213 8.1

24.5 2,553 1,891 (279) (390) 225 8.1

-% -% -% 0% -% 6% 0%

25.0 2,650 1,979 (172) (443) 307 7.9

25.0 2,650 1,979 (172) (442) 307 7.9

-% -% -% 0% (0%) (0%) 0%

25.4 2,730 2,050 (146) (449) 324 7.6

25.4 2,730 2,050 (147) (448) 323 7.6

-% -% -% 0% (0%) (0%) 0%

25.8 2,816 2,125 (152) (399) 362 7.2

25.8 2,816 2,125 (153) (399) 362 7.2

-% -% -% 0% (0%) (0%) 0%

DG (100% basis, 100% MQA owned): Traffic million Toll revenue US$m EBITDA US GAAP US$m Debt service US$m Tax paid US$m Dist'n to MQA A$m Net debt inc. acquisition debt US$m

19.2 92 74 (63) 1,023

18.5 92 72 (52) 1,033

18.5 92 72 (52) 1,033

-% -% -% -%

18.3 94 74 (53) 1,043

-% -% -% -%

18.7 99 78 (30) 1,044

-%

19.1 103 82 (39) 82 1,126

19.1 103 82 (39) 82 1,126

-% -% -% -%

-%

18.7 99 78 (30) 1,044

-% -% -% -%

-%

18.3 94 74 (53) 1,043

MQA fund level: Distributions received by MQA Mgmt and fund costs Other operating receipts MQA distributable CF Distribution to investors MQA cash balance

A$m A$m A$m A$m cps A$m

147 (37) (0) 109 20.0 40

213 (32) 1 182 24.0 57

225 (51) (5) 169 24.0 46

6% 59% (875%) (7%) -% (20%)

307 (29) 1 279 39.9 57

307 (49) (11) 247 36.2 46

(0%) 67% (1018%) (11%) (9%) (20%)

324 (30) 1 295 42.2 58

323 (30) 1 295 43.1 46

(0%) (2%) (22%) 0% 2% (20%)

466 (31) 1 437 62.5 58

466 (30) 1 437 64.0 46

(0%) (2%) (22%) 0% 2% (20%)

million

670

698

683

(2%)

698

683

(2%)

698

683

(2%)

698

683

(2%)

MQA shares on issue

-%

SOURCE: MORGANS RESEARCH, COMPANY

Figure 3: DPS forecast 70

64.0

60 15.3

52.7 0.3

50 43.1 0.0

A$ cps

units

36.2

40

30

24.0

20

16.0

18.0

48.7

20.0 36.2

13.2 10

5.7 13.2

16.0

52.3

43.1

18.0

20.0

24.0

5.7 0

Distribution excluding DG

Distribution from DG SOURCE: MORGANS RESEARCH, COMPANY

3

Toll Roads│Australia│Equity research│April 9, 2018

Figure 4: APRR management structure – before MQA internalisation

SOURCE: MQA

Figure 5: APRR management structure – after MQA internalisation

SOURCE: MQA

Figure 6: MQA deferred performance fees

SOURCE: MQA

4

Toll Roads│Australia│Equity research│April 9, 2018

Figure 7: MQA valuation summary December 2018 valuation date Millions unless otherwise stated 25% APRR (France) 100% Dulles Greenway (USA) NPV of external base fees NPV of external performance fees NPV of fund opex MQA cash Equity value Shares on issue MQA equity value per share

EV NPV local currency 19,605 1,465

EV/EBITDA x 9.9 19.9

Net debt 100% Equity local currency local currency (8,099) 11,506 (851) 615

MQA stake % 25.0% 100.0%

MQA debt (151) (188)

MQA Equity local currency 2,726 427

FX rate 0.639 0.781

MQA Equity A$ 4,265 547 (19) (186) 46 4,653 683 $6.81

SOURCE: MORGANS RESEARCH, COMPANY

Key risks which may have an impact on our investment view include: Traffic growth; Toll escalation (driven by CPI and capital investment); Currency exposure; Operating and capital cost control; Interest rates; Returns on new investment; Transition from external to internal management; Capital management; Change of tax laws; and M&A.

5

Toll Roads│Australia│Equity research│April 9, 2018

Queensland Brisbane

New South Wales +61 7 3334 4888

Stockbroking, Corporate Advice, Wealth Management

Sydney

Victoria +61 2 9043 7900

Stockbroking, Corporate Advice, Wealth Management

Melbourne

Western Australia +61 3 9947 4111

Stockbroking, Corporate Advice, Wealth Management

West Perth

+61 8 6160 8700

Stockbroking, Corporate Advice, Wealth Management

Brisbane: Edward St

+61 7 3121 5677

Armidale

+61 2 6770 3300

Brighton

+61 3 9519 3555

Perth

Brisbane: Tynan Partners

+61 7 3152 0600

Ballina Balmain

+61 2 6686 4144 +61 2 8755 3333

Camberwell Domain

+61 3 9813 2945 +61 3 9066 3200

+61 8 6462 1999

South SouthAustralia Australia

Brisbane: North Quay

+61 7 3245 5466

Bowral

+61 2 4851 5555

Geelong

+61 3 5222 5128

Adelaide

+61 8 8464 5000

Bundaberg

+61 7 4153 1050

Chatswood

+61 2 8116 1700

Richmond

+61 3 9916 4000

Norwood

+61 8 8461 2800

Cairns

+61 7 4222 0555

Coffs Harbour

+61 2 6651 5700

South Yarra

+61 3 8762 1400

Caloundra

+61 7 5491 5422

Gosford

+61 2 4325 0884

Southbank

+61 3 9037 9444

Gladstone

+61 7 4972 8000

Hurstville

+61 2 8215 5079

Traralgon

+61 3 5176 6055

Gold Coast

+61 7 5581 5777

Merimbula

+61 2 6495 2869

Warrnambool

+61 3 5559 1500

Ipswich/Springfield

+61 7 3202 3995

Mona Vale

+61 2 9998 4200

Kedron

+61 7 3350 9000

Neutral Bay

+61 2 8969 7500

Australian Capital Territory

Mackay

+61 7 4957 3033

Newcastle

+61 2 4926 4044

Canberra

Milton

+61 7 3114 8600

Orange

+61 2 6361 9166

Noosa

+61 7 5449 9511

Port Macquarie

+61 2 6583 1735

Northern Territory

Redcliffe

+61 7 3897 3999

Scone

+61 2 6544 3144

Darwin

Rockhampton

+61 7 4922 5855

Sydney: Level 7

+61 2 8216 5111

Spring Hill

+61 7 3833 9333

Currency House

Sunshine Coast Toowoomba

+61 7 5479 2757 +61 7 4639 1277

Sydney: Grosvenor Place

+61 2 8215 5000

Townsville

+61 7 4725 5787

Sydney Reynolds

+61 2 9373 4452

Securities Wollongong

+61 2 4227 3022

+61 2 6232 4999

+61 8 8981 9555

Tasmania Hobart

+61 3 6236 9000

Disclaimer The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual’s relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so. Those acting upon such information without advice do so entirely at their own risk. This report was prepared as private communication to clients of Morgans and is not intended for public circulation, publication or for use by any third party. The contents of this report may not be reproduced in whole or in part without the prior written consent of Morgans. While this report is based on information from sources which Morgans believes are reliable, its accuracy and completeness cannot be guaranteed. Any opinions expressed reflect Morgans judgement at this date and are subject to change. Morgans is under no obligation to provide revised assessments in the event of changed circumstances. This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment whatsoever.

Disclosure of interest Morgans may from time to time hold an interest in any security referred to in this report and may, as principal or agent, sell such interests. Morgans may previously have acted as manager or co-manager of a public offering of any such securities. Morgans affiliates may provide or have provided banking services or corporate finance to the companies referred to in the report. The knowledge of affiliates concerning such services may not be reflected in this report. Morgans advises that it may earn brokerage, commissions, fees or other benefits and advantages, direct or indirect, in connection with the making of a recommendation or a dealing by a client in these securities. Some or all of Morgans Authorised Representatives may be remunerated wholly or partly by way of commission.

Regulatory disclosures Analyst owns shares in the following mentioned company(ies): -

Recommendation structure For a full explanation of the recommendation structure, refer to our website at http://www.morgans.com.au/research_disclaimer

Research team For analyst qualifications and experience, refer to our website at http://www.morgans.com.au/research-and-markets/our-research-team

Stocks under coverage For a full list of stocks under coverage, refer to our website at http://www.morgans.com.au/research-and-markets/company-analysis/ASX100-Companies-under-coverage and http://www.morgans.com.au/research-and-markets/company-analysis/EX-100-Companies-under-coverage

Stock selection process For an overview on the stock selection process, refer to our website at http://www.morgans.com.au/research-and-markets/company-analysis

www.morgans.com.au If you no longer wish to receive Morgans publications please contact your local Morgans branch or write to GPO Box 202 Brisbane QLD 4001 and include your account details. 12.12.17

6